{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:56Z","timestamp":1793134136295,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.breast.2023.07.012","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T12:29:24Z","timestamp":1690460964000},"page":"74-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8884-1936","authenticated-orcid":false,"given":"Keris","family":"Poelhekken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel J.W.","family":"Greuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"van der Vegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Dorrius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertruida H.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.breast.2023.07.012_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca - Cancer J Clin"},{"issue":"1","key":"10.1016\/j.breast.2023.07.012_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13058-016-0705-5","article-title":"The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening","volume":"18","author":"van Luijt","year":"2016","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.breast.2023.07.012_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13058-020-01287-6","article-title":"Modeling the natural history of ductal carcinoma in situ based on population data","volume":"22","author":"Chootipongchaivat","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"4","key":"10.1016\/j.breast.2023.07.012_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.breast.2023.07.012_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1148\/radiol.211839","article-title":"Ductal carcinoma in situ: state-of-the-art review","volume":"302","author":"Grimm","year":"2022","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.breast.2023.07.012_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/bcr1397","article-title":"Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective","volume":"8","author":"Jones","year":"2006","journal-title":"Breast Cancer Res"},{"issue":"11","key":"10.1016\/j.breast.2023.07.012_bib7","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/bjc.2013.177","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"108","author":"Marmot","year":"2013","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.breast.2023.07.012_bib8","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/S0959-8049(03)00260-0","article-title":"Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening","volume":"39","author":"Yen","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2023.07.012_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2022.06.027","article-title":"Overdiagnosis of invasive breast cancer in population-based breast cancer screening: a short- and long-term perspective","volume":"173","author":"Ding","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2023.07.012_bib10","doi-asserted-by":"crossref","first-page":"g7773","DOI":"10.1136\/bmj.g7773","article-title":"Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods","volume":"350","author":"Carter","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.breast.2023.07.012_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030912","article-title":"Tumour growth models of breast cancer for evaluating early detection-A summary and a simulation study","volume":"15","author":"Strandberg","year":"2023","journal-title":"Cancers"},{"issue":"41","key":"10.1016\/j.breast.2023.07.012_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","article-title":"Epidemiology of ductal carcinoma in situ","volume":"2010","author":"Kerlikowske","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1_suppl","key":"10.1016\/j.breast.2023.07.012_bib13","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1177\/0272989X17741634","article-title":"The dana-farber CISNET model for breast cancer screening strategies: an update","volume":"38","author":"Lee","year":"2018","journal-title":"Med Decis Making"},{"issue":"5","key":"10.1016\/j.breast.2023.07.012_bib14","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2214\/ajr.184.5.01841391","article-title":"Reader agreement studies","volume":"184","author":"Crewson","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"10.1016\/j.breast.2023.07.012_bib15","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/hec.1148","article-title":"A taxonomy of model structures for economic evaluation of health technologies","volume":"15","author":"Brennan","year":"2006","journal-title":"Health Econ"},{"issue":"5","key":"10.1016\/j.breast.2023.07.012_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/0272989X12454579","article-title":"Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7","volume":"32","author":"Eddy","year":"2012","journal-title":"Med Decis Making"},{"issue":"4","key":"10.1016\/j.breast.2023.07.012_bib17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.breast.2015.03.013","article-title":"Simulation models in population breast cancer screening: a systematic review","volume":"24","author":"Koleva-Kolarova","year":"2015","journal-title":"Breast"},{"issue":"1_suppl","key":"10.1016\/j.breast.2023.07.012_bib18","doi-asserted-by":"crossref","first-page":"54S","DOI":"10.1177\/0272989X17711928","article-title":"Simulating the impact of risk-based screening and treatment on breast cancer outcomes with MISCAN-fadia","volume":"38","author":"van den Broek","year":"2018","journal-title":"Med Decis Making"},{"issue":"1_suppl","key":"10.1016\/j.breast.2023.07.012_bib19","doi-asserted-by":"crossref","first-page":"66S","DOI":"10.1177\/0272989X17698685","article-title":"Structure, function, and applications of the georgetown-einstein (GE) breast cancer simulation model","volume":"38","author":"Schechter","year":"2018","journal-title":"Med Decis Making"},{"issue":"1_suppl","key":"10.1016\/j.breast.2023.07.012_bib20","doi-asserted-by":"crossref","first-page":"78S","DOI":"10.1177\/0272989X17714473","article-title":"A bayesian simulation model for breast cancer screening, incidence, treatment, and mortality","volume":"38","author":"Huang","year":"2018","journal-title":"Med Decis Making"},{"issue":"1_suppl","key":"10.1016\/j.breast.2023.07.012_bib21","doi-asserted-by":"crossref","first-page":"99S","DOI":"10.1177\/0272989X17711927","article-title":"The university of Wisconsin breast cancer epidemiology simulation model: an update","volume":"38","author":"Alagoz","year":"2018","journal-title":"Med Decis Making"},{"issue":"13","key":"10.1016\/j.breast.2023.07.012_bib22","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1200\/JCO.2004.05.009","article-title":"Benefits and costs of interventions to improve breast cancer outcomes in African American women","volume":"22","author":"Mandelblatt","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2023.07.012_bib23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10549-013-2435-z","article-title":"Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis","volume":"138","author":"Batina","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2023.07.012_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/1055-9965.EPI-10-0944","article-title":"Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States","volume":"20","author":"van Ravesteyn","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.breast.2023.07.012_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10549-012-2274-3","article-title":"Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality","volume":"136","author":"Chang","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.breast.2023.07.012_bib26","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1287\/opre.1110.1019","article-title":"OR forum-A POMDP approach to personalize mammography screening decisions","volume":"60","author":"Ayer","year":"2012","journal-title":"Oper Res"},{"issue":"2","key":"10.1016\/j.breast.2023.07.012_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/0969141320974711","article-title":"The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada","volume":"28","author":"Yong","year":"2021","journal-title":"J Med Screen"},{"issue":"8","key":"10.1016\/j.breast.2023.07.012_bib28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2471\/BLT.18.207944","article-title":"Cost-effectiveness of risk-based breast cancer screening programme, China","volume":"96","author":"Sun","year":"2018","journal-title":"Bull World Health Organ"},{"issue":"9","key":"10.1016\/j.breast.2023.07.012_bib29","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1158\/1055-9965.EPI-11-1196","article-title":"Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined","volume":"21","author":"Heijnsdijk","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.breast.2023.07.012_bib30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/M20-2912","article-title":"Incorporating baseline breast density when screening women at average risk for breast cancer : a cost-effectiveness analysis","volume":"174","author":"Shih","year":"2021","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.breast.2023.07.012_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/jnci\/dju092","article-title":"Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography","volume":"106","author":"Stout","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.breast.2023.07.012_bib32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.14141237","article-title":"Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts","volume":"274","author":"Lee","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2023.07.012_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.vhri.2019.05.003","article-title":"The structure and parameterization of the breast cancer transition model among Chinese women","volume":"21","author":"Huang","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.breast.2023.07.012_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12885-018-4168-1","article-title":"Quality assurance target for community-based breast cancer screening in China: a model simulation","volume":"18","author":"Yang","year":"2018","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.breast.2023.07.012_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1524-4733.2007.00223.x","article-title":"Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia","volume":"11","author":"Rojnik","year":"2008","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.breast.2023.07.012_bib36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0969141320945736","article-title":"Estimating the natural progression of non-invasive ductal carcinoma in situ breast cancer lesions using screening data","volume":"28","author":"Weedon-Fekjaer","year":"2021","journal-title":"J Med Screen"},{"key":"10.1016\/j.breast.2023.07.012_bib37","doi-asserted-by":"crossref","first-page":"d7017","DOI":"10.1136\/bmj.d7017","article-title":"Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data","volume":"343","author":"Seigneurin","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.breast.2023.07.012_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2008.09.015","article-title":"Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland","volume":"45","author":"de Gelder","year":"2009","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.breast.2023.07.012_bib39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0010-4825(03)00003-9","article-title":"A computer model for the study of breast cancer","volume":"33","author":"Carter","year":"2003","journal-title":"Comput Biol Med"},{"issue":"5","key":"10.1016\/j.breast.2023.07.012_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097459","article-title":"Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model","volume":"9","author":"Comas","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.breast.2023.07.012_bib41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/0740817X.2014.959671","article-title":"Combined DES\/SD model of breast cancer screening for older women, I: natural-history simulation","volume":"47","author":"Tejada","year":"2015","journal-title":"IIE Trans"},{"issue":"17","key":"10.1016\/j.breast.2023.07.012_bib42","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1088\/0031-9155\/55\/17\/021","article-title":"A Monte Carlo tool to simulate breast cancer screening programmes","volume":"55","author":"Forastero","year":"2010","journal-title":"Phys Med Biol"},{"issue":"4","key":"10.1016\/j.breast.2023.07.012_bib43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.breast.2015.03.012","article-title":"Cost-effectiveness of breast cancer screening policies using simulation","volume":"24","author":"Gocgun","year":"2015","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.breast.2023.07.012_bib44","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jval.2017.04.012","article-title":"Evaluation of a stratified national breast screening program in the United Kingdom: an early model-based cost-effectiveness analysis","volume":"20","author":"Gray","year":"2017","journal-title":"Value Health"},{"issue":"10","key":"10.1016\/j.breast.2023.07.012_bib45","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/bjc.2014.206","article-title":"Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom","volume":"110","author":"Gunsoy","year":"2014","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.breast.2023.07.012_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cdp.2004.08.003","article-title":"Simulation modeling of change to breast cancer detection age eligibility recommendations in Ontario, 2002-2021","volume":"28","author":"Hunter","year":"2004","journal-title":"Cancer Detect Prev"},{"issue":"3","key":"10.1016\/j.breast.2023.07.012_bib47","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/curroncol29030136","article-title":"The OncoSim-breast cancer microsimulation model","volume":"29","author":"Yong","year":"2022","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.breast.2023.07.012_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-011-1430-5","article-title":"Characterizing the impact of 25 years of DCIS treatment","volume":"129","author":"Ozanne","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.breast.2023.07.012_bib49","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jval.2015.06.006","article-title":"Modeling the cost-effectiveness of alternative upper age limits for breast cancer screening in england and wales","volume":"19","author":"Rafia","year":"2016","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.breast.2023.07.012_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv372","article-title":"Outcomes of active surveillance for ductal carcinoma in situ: a computational risk analysis","volume":"108","author":"Ryser","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.breast.2023.07.012_bib51","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jval.2017.04.009","article-title":"The long-term effectiveness and cost effectiveness of organized versus opportunistic screening for breast cancer in Austria","volume":"20","author":"Schiller-Fruehwirth","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.breast.2023.07.012_bib52","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/2193-1801-2-366","article-title":"Is Age-targeted full-field digital mammography screening cost-effective in emerging countries? A micro simulation model","volume":"2","author":"Souza","year":"2013","journal-title":"SpringerPlus"},{"issue":"8","key":"10.1016\/j.breast.2023.07.012_bib53","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/bjc.2013.471","article-title":"Quantifying the natural history of breast cancer","volume":"109","author":"Tan","year":"2013","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.breast.2023.07.012_bib54","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/cncr.22848","article-title":"Cost effectiveness of mammography screening for Chinese women","volume":"110","author":"Wong","year":"2007","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.breast.2023.07.012_bib55","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1002\/cncr.27448","article-title":"Optimizing resource allocation for breast cancer prevention and care among Hong Kong Chinese women","volume":"118","author":"Wong","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.breast.2023.07.012_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-155-1-201107050-00003","article-title":"Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness","volume":"155","author":"Schousboe","year":"2011","journal-title":"Ann Intern Med"},{"issue":"Suppl 3","key":"10.1016\/j.breast.2023.07.012_bib57","first-page":"38","article-title":"Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling","volume":"16","author":"Wong","year":"2010","journal-title":"Hong Kong Med J"},{"issue":"3","key":"10.1016\/j.breast.2023.07.012_bib58","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ijc.30105","article-title":"Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: a systematic review","volume":"139","author":"Segnan","year":"2016","journal-title":"Int J Cancer"},{"issue":"5 Suppl","key":"10.1016\/j.breast.2023.07.012_bib59","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.21614\/chirurgia.116.5.suppl.S7","article-title":"The natural history of ductal carcinoma in situ of the breast - an overview","volume":"116","author":"Fredholm","year":"2021","journal-title":"Chirurgia"},{"issue":"1_suppl","key":"10.1016\/j.breast.2023.07.012_bib60","doi-asserted-by":"crossref","first-page":"126S","DOI":"10.1177\/0272989X17729358","article-title":"Modeling ductal carcinoma in situ (DCIS): an overview of CISNET model approaches","volume":"38","author":"van Ravesteyn","year":"2018","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.breast.2023.07.012_bib61","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-018-05082-y","article-title":"Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in The Netherlands","volume":"174","author":"van Dooijeweert","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"5 Suppl","key":"10.1016\/j.breast.2023.07.012_bib62","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.21614\/chirurgia.116.5.suppl.S15","article-title":"Epidemiology of ductal carcinoma in situ","volume":"116","author":"Iatrakis","year":"2021","journal-title":"Chirurgia"},{"issue":"3","key":"10.1016\/j.breast.2023.07.012_bib63","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1309\/AJCPW4EADZ9BNXXM","article-title":"Regressive change in high-grade ductal carcinoma in situ of the breast: histopathologic spectrum and biologic importance","volume":"144","author":"Wasserman","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.breast.2023.07.012_bib64","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jval.2012.06.012","article-title":"Modeling good research practices--overview: a report of the ISPOR-SMDM modeling good research practices task force--1","volume":"15","author":"Caro","year":"2012","journal-title":"Value Health"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623005350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623005350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:47:19Z","timestamp":1760777239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977623005350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":64,"alternative-id":["S0960977623005350"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2023.07.012","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2023.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}